Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
busulfan, Quantity: 60 mg
Arrotex Pharmaceuticals Pty Ltd
Busulfan
Injection, solution
Excipient Ingredients: macrogol 400; dimethylacetamide
Intravenous Infusion
8
(S4) Prescription Only Medicine
Busulfan injection is indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.
Visual Identification: A clear and colorless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2014-10-09